Schmidt-Wolf IG - Search Results

1

Clinical studies applying cytokine-induced killer cells for the treatment of gastrointestinal tumors.

Jäkel CE, Vogt A, Gonzalez-Carmona MA, Schmidt-Wolf IG. Jäkel CE, et al. J Immunol Res. 2014;2014:897214. doi: 10.1155/2014/897214. Epub 2014 Jan 16. J Immunol Res. 2014. PMID: 24741629 Free PMC article. Review.

2

Current clinical and laboratory strategies to augment the efficacy of immunotherapy in multiple myeloma.

Gorschlüter M, Ziske C, Glasmacher A, Schmidt-Wolf IG. Gorschlüter M, et al. Clin Cancer Res. 2001 Aug;7(8):2195-204. Clin Cancer Res. 2001. PMID: 11489792 Review.

3

Enhanced lytic activity of cytokine-induced killer cells against multiple myeloma cells after co-culture with idiotype-pulsed dendritic cells.

Märten A, Renoth S, von Lilienfeld-Toal M, Buttgereit P, Schakowski F, Glasmacher A, Sauerbruch T, Schmidt-Wolf IG. Märten A, et al. Haematologica. 2001 Oct;86(10):1029-37. Haematologica. 2001. PMID: 11602408

4

Interactions between dendritic cells and cytokine-induced killer cells lead to an activation of both populations.

Märten A, Ziske C, Schöttker B, Renoth S, Weineck S, Buttgereit P, Schakowski F, von Rücker A, Sauerbruch T, Schmidt-Wolf IG. Märten A, et al. J Immunother. 2001 Nov-Dec;24(6):502-10. doi: 10.1097/00002371-200111000-00007. J Immunother. 2001. PMID: 11759073

5

Therapeutic vaccination against metastatic renal cell carcinoma by autologous dendritic cells: preclinical results and outcome of a first clinical phase I/II trial.

Märten A, Flieger D, Renoth S, Weineck S, Albers P, Compes M, Schöttker B, Ziske C, Engelhart S, Hanfland P, Krizek L, Faber C, von Ruecker A, Müller S, Sauerbruch T, Schmidt-Wolf IG. Märten A, et al. Cancer Immunol Immunother. 2002 Dec;51(11-12):637-44. doi: 10.1007/s00262-002-0324-0. Epub 2002 Oct 3. Cancer Immunol Immunother. 2002. PMID: 12439609 Free PMC article. Clinical Trial.

6

Telomerase pulsed dendritic cells for immunotherapy for renal cell carcinoma.

Sievers E, Albers P, Schmidt-Wolf IG, Märten A. Sievers E, et al. J Urol. 2004 Jan;171(1):114-9. doi: 10.1097/01.ju.0000094803.60928.d7. J Urol. 2004. PMID: 14665857

7

Dendritic cell, the immunotherapeutic cell for cancer.

Nagaraj S, Ziske C, Schmidt-Wolf IG. Nagaraj S, et al. Indian J Med Res. 2004 Apr;119(4):133-8. Indian J Med Res. 2004. PMID: 15147117 Review.

8

Transfection of human monocyte-derived dendritic cells with CpG oligonucleotides.

Erhardt M, Gorschlüter M, Sager J, Ziske C, Strehl J, Lilienfeld-Toal MV, Schmidt-Wolf IG. Erhardt M, et al. Immunol Cell Biol. 2005 Jun;83(3):278-85. doi: 10.1111/j.1440-1711.2005.01328.x. Immunol Cell Biol. 2005. PMID: 15877606

9

Patient-derived dendritic cells transduced with an a-fetoprotein-encoding adenovirus and co-cultured with autologous cytokine-induced lymphocytes induce a specific and strong immune response against hepatocellular carcinoma cells.

González-Carmona MA, Märten A, Hoffmann P, Schneider C, Sievers E, Schmidt-Wolf IG, Sauerbruch T, Caselmann WH. González-Carmona MA, et al. Liver Int. 2006 Apr;26(3):369-79. doi: 10.1111/j.1478-3231.2005.01235.x. Liver Int. 2006. PMID: 16584401

10

Activated gammadelta T cells express the natural cytotoxicity receptor natural killer p 44 and show cytotoxic activity against myeloma cells.

von Lilienfeld-Toal M, Nattermann J, Feldmann G, Sievers E, Frank S, Strehl J, Schmidt-Wolf IG. von Lilienfeld-Toal M, et al. Clin Exp Immunol. 2006 Jun;144(3):528-33. doi: 10.1111/j.1365-2249.2006.03078.x. Clin Exp Immunol. 2006. PMID: 16734623 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

337 results

Search Page